Transcriptional instability during evolving sepsis may limit biomarker based risk stratification

Area of Science:

• Pediatric critical care medicine
• Genomics and transcriptomics
• Infectious diseases

Background:

• Sepsis poses a significant global health threat to children, leading to high rates of illness and death.
• Early sepsis recognition and treatment are crucial for improving outcomes.
• Genomic studies offer potential for identifying new diagnostic markers and therapeutic targets.

Purpose of the Study:

• To examine dynamic gene expression patterns during the progression of sepsis-induced multi-organ failure in children.
• To investigate the impact of *Neisseria meningitidis* infection on temporal gene expression in previously healthy children.

Main Methods:

• RNA was isolated from serial blood samples collected over 48 hours from five critically ill children with meningococcal sepsis.
• Gene expression profiling was performed using Affymetrix arrays.
• Data analysis involved GeneSpring software and Ingenuity Pathway Analysis.

Main Results:

• Significant variability in gene expression was observed across different time points and between patients.
• Dynamic changes were noted in immune and inflammatory gene networks.
• Temporal variations were also found in proposed diagnostic and risk stratification biomarkers, not fully explained by clinical presentation.

Conclusions:

• This study provides the first detailed account of extensive gene expression changes during pediatric sepsis evolution.
• Static, single-time-point biomarker assessments may be insufficient for accurate risk stratification in sepsis.
• Serial measurements and comprehensive network analyses are likely necessary for optimizing management of evolving sepsis.